viral
etiolog
respiratori
tract
infect
rti
less
studi
adult
pediatr
popul
furthermor
abil
pcrelectrospray
ioniz
mass
spectrometri
pcresim
detect
enterovirus
rhinovirus
respiratori
sampl
well
evalu
sought
use
pcresim
comprehens
investig
viral
epidemiolog
adult
rti
includ
test
rhinovirus
enterovirus
nasopharyng
throat
swab
adult
acut
rti
upper
rti
lower
rti
visit
local
clinic
outpati
emerg
depart
medic
center
taiwan
octob
june
test
respiratori
virus
viru
isol
pcresim
throat
swab
patient
bacteri
infect
individu
without
activ
infect
includ
control
sampl
respiratori
virus
found
case
viru
isol
pcresim
method
respect
method
use
influenza
viru
rhinovirus
frequent
identifi
virus
wherea
human
coronavirus
human
metapneumoviru
hmpv
enterovirus
adenovirus
respiratori
syncyti
viru
parainfluenza
virus
identifi
small
proport
case
case
type
viru
coinfect
observ
case
control
group
sampl
test
posit
respiratori
viru
pcresim
patient
undergo
steroid
treatment
activ
malign
suffer
chronic
obstruct
pulmonari
diseas
copd
risk
rhinoviru
hmpv
parainfluenza
infect
respect
overal
immunocompromis
patient
patient
copd
patient
receiv
dialysi
risk
noninfluenza
respiratori
viru
infect
rhinovirus
influenza
viru
parainfluenza
virus
common
virus
involv
case
lower
rti
factor
parainfluenza
infect
old
age
immunosuppress
independ
associ
lower
rti
conclus
pcresim
improv
diagnost
yield
viral
rti
noninfluenza
respiratori
viru
infect
associ
patient
comorbid
lower
rti
addit
studi
delin
clinic
need
includ
noninfluenza
respiratori
virus
diagnost
workup
popul
warrant
medicin
abbrevi
cci
charlson
comorbid
index
cmv
cytomegaloviru
copd
chronic
obstruct
pulmonari
diseas
ebv
epsteinbarr
viru
hcov
human
coronaviru
hhv
human
herpesviru
hmpv
human
metapneumoviru
herp
simplex
virus
lrti
lower
respiratori
tract
infect
nat
nucleic
acid
test
nckuh
nation
chengkung
univers
hospit
pcresim
pcrelectrospray
ioniz
mass
spectrometri
rsv
respiratori
syncyti
viru
rti
respiratori
tract
infect
urti
upper
respiratori
tract
infect
vzv
varicella
zoster
viru
editor
seiho
nagafuchi
one
case
codetect
rhinoviru
codetect
parainfluenza
type
includ
sampl
match
influenza
pcresim
z
includ
sampl
match
enteroviru
rhinoviru
pcresim
v
iral
respiratori
tract
infect
rti
human
occur
throughout
year
repres
major
caus
clinic
visit
worldwid
past
viral
caus
rti
larg
unknown
primarili
due
insensit
culturebas
method
detect
virus
narrow
spectrum
viral
detect
use
singleplex
nucleic
acid
test
nat
recent
develop
multiplex
respiratori
nat
allow
simultan
rapid
sensit
detect
multipl
virus
facilit
comprehens
studi
regard
epidemiolog
viral
rti
current
viral
epidemiolog
rti
studi
extens
among
pediatr
popul
compar
adult
popul
throughout
world
similarli
studi
describ
viral
etiolog
respiratori
ill
taiwan
subtrop
countri
eastern
asia
limit
pediatr
popul
thu
studi
among
adult
patient
lack
particularli
regard
infect
due
fastidi
newli
identifi
virus
human
metapneumoviru
hmpv
human
coronaviru
hcov
overlap
clinic
present
share
differ
respiratori
virus
make
differenti
diagnos
difficult
perform
base
sole
clinic
paramet
moreov
effect
antivir
agent
current
restrict
influenza
viru
infect
henc
better
understand
epidemiolog
adult
viral
rti
would
aid
futur
design
diagnost
strategi
infect
control
patient
manag
among
variou
multiplex
nat
multilocu
polymeras
chain
reaction
coupl
electrospray
ioniz
mass
spectrometri
pcresim
simultan
identifi
subtyp
multipl
respiratori
virus
despit
diagnost
potenti
abil
pcresim
detect
human
enteroviru
rhinoviru
respiratori
sampl
patient
rti
well
evalu
previou
pcresim
studi
patient
rti
includ
virus
diagnost
panel
expand
upon
previou
studi
util
pcresim
respiratori
viru
detect
aim
comprehens
investig
epidemiolog
adult
viral
rti
use
pcresim
compar
diagnost
perform
pcresim
convent
cultur
method
identifi
multipl
clinic
relev
respiratori
virus
includ
enteroviru
rhinoviru
conduct
comprehens
epidemiolog
studi
includ
patient
without
comorbid
enrol
adult
least
yr
age
acut
rti
within
day
onset
treat
local
outpati
clinic
yc
hospit
outpati
emerg
depart
nation
chengkung
univers
hospit
nckuh
universityaffili
medic
center
southern
taiwan
octob
june
acut
rti
defin
simultan
occurr
least
respiratori
symptom
sign
new
worsen
cough
sputum
product
sore
throat
nasal
congest
rhinorrhea
dyspnea
wheez
inject
tonsil
least
follow
symptom
fever
chill
cough
lower
rti
lrti
defin
presenc
acut
rti
new
infiltr
chest
radiograph
patient
experienc
episod
rti
recent
episod
count
separ
patient
fulli
recov
previou
episod
least
interv
onset
episod
clinic
laboratori
radiolog
data
contact
histori
patient
retriev
comorbid
assess
patient
base
charlson
comorbid
index
cci
steroid
use
defin
receipt
corticosteroid
treatment
mg
prednisolon
equival
daili
dosag
week
immunocompromis
state
diagnos
patient
met
one
follow
condit
corticosteroid
treatment
solid
organ
hematopoiet
stem
cell
recipi
chemotherapi
underli
malign
past
month
nasopharyng
throat
swab
obtain
patient
collect
transport
medium
previous
describ
viru
detect
identif
viru
isol
pcresim
clinic
specimen
store
transport
studi
site
within
hour
collect
throat
swab
case
without
respiratori
infect
month
prior
enrol
includ
control
sampl
pcresim
analysi
includ
patient
exclus
bacteri
infect
document
case
bacteremia
urinari
tract
infect
admit
nckuh
individu
without
activ
infect
subject
without
activ
infect
includ
patient
stabl
chronic
diseas
follow
nckuh
clinic
healthi
individu
whose
medic
inform
collect
use
clinic
questionnair
studi
approv
institut
review
board
studi
hospit
patient
provid
inform
consent
respiratori
specimen
inocul
onto
appropri
tissu
cultur
madindarbi
canin
kidney
rhabdomyosarcoma
isol
human
influenza
viru
parainfluenza
viru
genu
enteroviru
cytomegaloviru
cmv
adenoviru
respiratori
syncyti
viru
rsv
herp
simplex
virus
varicella
zoster
viru
vzv
isol
identif
virus
perform
use
previous
describ
method
enterovirus
identifi
immunofluoresc
assay
use
chemicon
pan
ev
mix
crossreact
rhinoviru
light
diagnost
chemicon
millipor
viru
detect
identif
pcresim
total
nucleic
acid
extract
ml
swab
sampl
use
nucleic
acid
autoextractor
magna
pure
compact
instrument
mannheim
germani
eluat
store
analysi
analys
extract
nucleic
acid
ad
plexid
respiratori
viru
assay
plate
plexid
broad
viral
assay
plate
plexid
abbott
laboratori
abbott
park
illinoi
plexid
respiratori
viru
assay
detect
human
adenoviru
hcov
hmpv
influenza
b
parainfluenza
type
rsv
wherea
plexid
broad
viral
assay
detect
human
adenoviru
enteroviru
rhinoviru
bk
jc
polyomaviru
parvoviru
vzv
epsteinbarr
viru
ebv
cmv
human
herpesviru
hhv
studi
respiratori
virus
refer
adenoviru
hcov
hmpv
influenza
parainfluenza
rsv
enteroviru
rhinoviru
nucleic
acid
amplif
analys
pcr
product
conduct
use
pcresim
platform
plexid
abbott
laboratori
follow
manufactur
instruct
test
turnaround
time
sampl
result
within
hour
pcresim
analys
includ
autom
pcr
desalt
esim
signal
acquisit
spectral
analysi
data
report
organ
identif
base
total
mass
base
composit
pcr
amplicon
compar
molecular
signatur
databas
establish
plexid
manufactur
sampl
pcresim
result
disagre
cultur
result
speci
level
reexamin
second
molecular
method
enterovirus
rhinoviru
differenti
enteroviru
use
convent
pcr
sequenc
analysi
previous
describ
primer
rhinoviru
blast
search
analys
perform
statist
packag
social
scienc
version
spss
inc
chicago
il
continu
variabl
express
mean
valu
ae
standard
deviat
compar
use
analysi
varianc
test
categor
variabl
compar
use
fisher
exact
test
x
test
biolog
plausibl
variabl
p
valu
univari
analysi
consid
inclus
logist
regress
model
multivari
analysi
p
valu
less
consid
statist
signific
test
studi
period
total
episod
acut
rti
patient
record
includ
episod
local
clinic
episod
nckuh
outpati
emerg
depart
conveni
episod
count
case
overal
case
male
patient
patient
year
age
respect
twohundr
twelv
patient
present
upper
rti
urti
case
present
lrti
compar
patient
attend
local
clinic
patient
attend
medic
care
center
older
comorbid
tabl
detail
demograph
data
rti
case
control
case
present
tabl
respiratori
sampl
rti
case
examin
virus
viru
isol
pcresim
result
present
tabl
viru
isol
respiratori
virus
detect
case
includ
influenza
case
enteroviru
parainfluenza
viru
coinfect
detect
viru
isol
identifi
addit
parainfluenza
type
enteroviru
infect
found
pcresim
sampl
pcresim
respiratori
virus
detect
case
influenza
case
frequent
identifi
viru
among
case
subtyp
pandem
viru
case
season
viru
case
influenza
match
pandem
season
genu
enteroviru
secondmost
frequent
detect
viru
includ
rhinoviru
enteroviru
cultureneg
case
match
rhinoviru
enteroviru
hcov
hmpv
adenoviru
rsv
parainfluenza
detect
small
proport
case
simultan
detect
respiratori
viru
observ
patient
rhinoviru
case
like
codetect
anoth
respiratori
viru
tabl
note
cultiv
virus
identifi
enteroviru
reactiv
chemicon
pan
ev
mix
character
rhinoviru
pcresim
pcrsequenc
analysi
clinic
specimen
confirm
exist
rhinovirus
enterovirus
pcresim
identifi
addit
respiratori
virus
cultureneg
sampl
mostli
rhinoviru
sampl
second
respiratori
viru
cultureposit
influenza
sampl
overal
posit
detect
rate
respiratori
viru
cultur
pcresim
method
respect
specimen
posit
method
pcresim
cultur
method
reach
level
agreement
speci
level
influenza
parainfluenza
genu
level
genu
enteroviru
control
group
healthi
individu
test
posit
respiratori
viru
rhinoviru
pcresim
respect
herpesvirus
pcresim
identifi
ebv
cmv
vzv
sampl
rti
case
similar
detect
rate
observ
control
group
detect
polyomaviru
parvoviru
viru
sampl
case
rti
control
group
case
test
posit
respiratori
viru
either
cultur
pcresim
analyz
posit
detect
rate
declin
age
group
respect
p
figur
higher
posit
rate
observ
patient
urti
patient
lrti
vs
p
tabl
figur
similar
distribut
respiratori
virus
case
local
clinic
medic
center
tabl
patient
age
group
figur
case
identifi
respiratori
virus
noninfluenza
viru
infect
common
patient
lrti
urti
vs
p
rhinoviru
influenza
parainfluenza
lead
respiratori
virus
involv
case
lrti
parainfluenza
frequent
observ
lrti
group
urti
group
tabl
figur
season
variat
individu
respiratori
viru
period
patient
identifi
respiratori
virus
univari
analysi
reveal
patient
follow
condit
like
noninfluenza
respiratori
viru
infect
immunocompromis
state
chronic
obstruct
pulmonari
diseas
copd
chronic
renal
failur
receiv
dialysi
ci
p
multivari
analysi
demonstr
steroid
use
independ
risk
factor
rhinoviru
infect
ci
p
activ
malign
independ
risk
factor
hmpv
infect
ci
p
copd
independ
risk
factor
parainfluenza
infect
ci
compar
urti
lrti
group
factor
found
associ
lrti
univari
analysi
includ
old
age
year
high
comorbid
index
congest
heart
failur
copd
malign
immunocompromis
state
detect
parainfluenza
ebv
wherea
detect
influenza
less
frequent
associ
lrti
codetect
respiratori
viru
associ
develop
lrti
multivari
analysi
old
age
immunocompromis
state
detect
parainfluenza
remain
independ
factor
associ
lrti
tabl
among
episod
singl
respiratori
viru
infect
arthralgia
frequent
observ
influenza
infect
noninfluenza
infect
vs
p
type
infect
examin
symptom
includ
sore
throat
rhinorrhea
cough
purul
sputum
wheez
dyspnea
headach
detect
similar
frequenc
case
lrti
coinfect
bacteri
pathogen
sputum
cultur
blood
cultur
found
patient
test
posit
respiratori
virus
patient
test
neg
respiratori
virus
four
case
influenza
lrti
receiv
oseltamivir
two
patient
die
pneumonia
worsen
underli
malign
patient
test
posit
hmpv
patient
test
neg
respiratori
viru
four
studi
viral
epidemiolog
adult
acut
rti
use
pcresim
technolog
major
advantag
first
expand
previou
studi
util
pcresim
respiratori
viru
detect
plexid
broad
viral
assay
target
enteroviru
rhinoviru
herpesvirus
jc
bk
polyomavirus
parvoviru
plexid
respiratori
viru
assay
test
adopt
detect
multipl
clinic
relev
respiratori
virus
second
control
group
patient
exclus
bacteri
infect
individu
without
activ
infect
enrol
elimin
falseposit
artifact
nat
estim
preval
detect
asymptomat
carrier
respiratori
virus
third
studi
enrol
immunocompet
immunocompromis
patient
visit
local
clinic
medic
center
present
urti
lrti
reflect
true
viral
epidemiolog
adult
rti
supplement
convent
cultur
method
pcresim
increas
respiratori
viru
detect
rate
achiev
cultur
alon
combin
method
diagnost
gain
observ
cultur
virus
especi
rhinoviru
fastidi
virus
although
compar
altern
nat
due
sampl
volum
limit
report
pcr
esim
high
sensit
specif
variabl
respiratori
viru
detect
rel
immunolog
pcrbase
method
gold
standard
assay
except
parainfluenza
sensit
coincident
found
parainfluenza
type
virus
detect
pcresim
potenti
caus
contribut
lower
detect
rate
parainfluenza
remain
explor
posit
detect
rate
respiratori
virus
pcresim
present
studi
similar
parallel
adult
surveil
program
use
nat
notabl
higher
earlier
studi
use
ibi
biosensor
system
prototyp
pcresi
ms
use
respiratori
viru
surveil
ii
kit
like
kit
design
detect
enteroviru
rhinoviru
enteroviru
rhinoviru
member
enteroviru
genu
contribut
rti
case
studi
adult
case
studi
consid
preval
enteroviru
rhinoviru
includ
diagnost
panel
respiratori
virus
comprehens
viral
detect
indic
codetect
rate
within
rang
report
elsewher
rhinoviru
viru
frequent
involv
coinfect
probabl
due
high
preval
throughout
year
influenza
rhinoviru
frequent
detect
respiratori
virus
wherea
hcov
hmpv
enteroviru
adenoviru
rsv
parainfluenza
detect
small
proport
case
find
similar
viral
epidemiolog
adult
rti
observ
studi
group
similar
distribut
virus
case
local
clinic
medic
center
patient
age
group
suggest
individu
age
group
suscept
multipl
respiratori
virus
simultan
circul
commun
lower
posit
detect
rate
observ
elderli
popul
probabl
older
adult
patient
shed
lower
titer
virus
howev
role
ebv
cmv
adult
rti
remain
incomplet
moreov
univari
associ
ebv
lrti
observ
studi
may
caus
confound
factor
age
particularli
given
old
age
identifi
independ
factor
ebv
detect
data
shown
lack
detect
bk
jc
polyomaviru
parvoviru
impli
virus
play
minor
role
adult
rti
oropharyng
cell
involv
bk
jc
polyomaviru
persist
furthermor
low
posit
detect
rate
respiratori
virus
control
group
suggest
low
possibl
falseposit
artifact
pcresim
lower
rate
asymptomat
colon
respiratori
virus
addit
advantag
sensit
detect
pcr
esim
possess
capabl
simultan
subtyp
identif
respiratori
virus
studi
influenza
virus
subtyp
pandem
influenza
season
influenza
europ
virus
cocircul
commun
influenza
season
genu
enteroviru
acidlabil
rhinoviru
differenti
enteroviru
use
acid
labil
test
pcresim
rapidli
differenti
speci
singl
test
demonstr
studi
hcov
subtyp
valid
convent
pcrsequenc
assay
data
shown
newli
identifi
detect
studi
period
low
detect
rate
report
china
understand
role
noninfluenza
respiratori
virus
patient
comorbid
lrti
strengthen
studi
patient
undergo
steroid
treatment
activ
malign
suffer
copd
risk
rhinoviru
hmpv
parainfluenza
infect
respect
overal
immunocompromis
patient
copd
patient
receiv
dialysi
risk
noninfluenza
respiratori
viru
infect
noninfluenza
viru
infect
also
frequent
involv
lrti
urti
among
lrti
rhinoviru
parainfluenza
rank
firstand
thirdmost
common
pathogen
respect
parainfluenza
independ
factor
associ
lrti
find
consist
prior
report
virus
signific
caus
lrti
hand
despit
increas
role
noninfluenza
respiratori
virus
current
avail
antivir
agent
vaccin
primarili
target
influenza
infect
although
viral
rti
selflimit
ill
observ
major
patient
lrti
recov
ill
without
aid
antivir
agent
definit
etiolog
diagnosi
help
reduc
unwarr
use
antiinfluenza
agent
antimicrobi
andor
unnecessari
hospit
provid
use
inform
control
rti
howev
observ
clinic
differenti
influenza
infect
respiratori
viru
infect
difficult
due
overlap
symptom
describ
previous
collect
associ
noninfluenza
viru
infect
patient
comorbid
lrti
report
suggest
complet
respiratori
viral
panel
would
appropri
diagnost
workup
rti
popul
addit
cost
incur
use
complet
panel
pcresimsbas
assess
molecular
test
would
like
offset
accompani
reduct
unnecessari
antimicrobi
therapi
andor
hospit
studi
limit
first
parainfluenza
type
newli
identifi
respiratori
virus
human
bocaviru
human
polyomaviru
ki
wu
polyomaviru
includ
panel
role
adult
rti
taiwan
unclear
second
although
certain
risk
factor
specif
viru
infect
hmpv
parainfluenza
infect
identifi
associ
reexamin
addit
largescal
clinic
studi
clinic
impact
underli
mechan
associ
explor
similarli
control
case
may
need
better
estim
preval
asymptomat
carrier
respiratori
virus
third
season
cover
season
viral
respiratori
infect
could
demonstr
conclus
compar
viru
isol
pcresim
produc
greater
diagnost
yield
viral
rti
low
possibl
falseposit
artifact
noninfluenza
respiratori
viru
infect
significantli
associ
patient
comorbid
lrti
addit
studi
delin
clinic
need
econom
benefit
includ
noninfluenza
respiratori
virus
diagnost
workup
popul
warrant
